Vol 2015, No 2 (2015)

Table of Contents

Licensing

Theravance Finds a Good Match for its Phase III-Ready Nebulised COPD Therapy in Mylan Abstract
Heather Cartwright

Mergers & Acquisitions

Shire’s Bet on NPS Pharma Pays Off with Natpara® Approval Abstract
Heather Cartwright
Pfizer’s US$17 B Buyout of Hospira Paves the Way for a Split Abstract
Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.